Human leukocyte antigen-B (-Bw6/-Bw4 I80, T80) and human leukocyte antigen-C (-C1/-C2) subgrouping using pyrosequence analysis

Hum Immunol. 2011 Oct;72(10):859-68. doi: 10.1016/j.humimm.2011.05.007. Epub 2011 May 24.

Abstract

Specific combinations of killer immunoglobulin-like receptors (KIR) and human leukocyte antigen (HLA) class I molecules characterized by a particular residue 80 are significantly associated with outcomes in different pathologic conditions, such as autoimmunity, pathogenic infection, cancer, and reproductive failure. Thus, a simplified method for HLA typing used in association with the analysis of KIR genotype (Kirotype) is of particular interest to extend the analysis of larger series. Here, we describe a quick and inexpensive method that allows use of pyrosequencing, a helpful subtyping of HLA class I molecules, into HLA-Bw6, -Bw4 I(80) or -Bw4 T(80), HLA-C1, or -C2 groups and HLA-A allotypes sharing Bw4+ epitope or the rare HLA-B allotypes displaying the C1 motif. In particular, this analysis is focused on the amino acids around residue 80, known to be relevant in defining the affinity of KIR/HLA interaction and in the functional effects. This method was demonstrated to have good sensitivity, specificity, and reproducibility of detection and it was validated using a panel of HLA-typed International Histocompatibility Workshop (IHW) cell lines and clinical isolates. Using an allele quantitative acquisition mode, the method permitted us to obtain an accurate sequencing as required in heterozygous and/or homozygous sample definition.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alleles
  • Amino Acid Sequence
  • Autoimmunity / genetics*
  • Cell Line
  • Epitopes / analysis*
  • Epitopes / genetics
  • Epitopes / immunology
  • Genotype
  • HLA-B Antigens / analysis*
  • HLA-B Antigens / genetics
  • HLA-B Antigens / immunology
  • HLA-C Antigens / analysis*
  • HLA-C Antigens / genetics
  • HLA-C Antigens / immunology
  • Heterozygote
  • Histocompatibility Testing / methods*
  • Homozygote
  • Humans
  • Leukocytes / chemistry*
  • Leukocytes / cytology
  • Leukocytes / immunology
  • Molecular Sequence Data
  • Molecular Typing / methods*
  • Receptors, KIR3DL1 / analysis*
  • Receptors, KIR3DL1 / genetics
  • Receptors, KIR3DL1 / immunology
  • Reproducibility of Results
  • Sensitivity and Specificity
  • Sequence Alignment
  • Sequence Analysis, DNA / methods*

Substances

  • Epitopes
  • HLA-B Antigens
  • HLA-C Antigens
  • Receptors, KIR3DL1